Investigating the effect of sotalol on the repolarization intervals in healthy young individuals.

BACKGROUND The dissociation between a drug-induced increase of the QT interval prolongation and an increased risk for ventricular arrhythmias has been suggested by academic investigators and regulatory agencies. Yet, there are no alternative or complimentary electrocardiographic (ECG) techniques available for assessing the cardiotoxicity of novel compounds. In this study, we investigated a set of novel ECG parameters quantifying the morphology of the T-loop. In a group of healthy individuals exposed to sotalol, we compared their drug-induced changes to the drug-induced prolongations of the QTc, QTc apex and T-peak to T-end intervals. METHODS We implemented a set of parameters describing the morphology of the T loop in its preferential plane. These parameters measure the time interval needed for the heart vector amplitude to change from its maximum value to a time when its amplitude has been reduced by 30%, 50%, and 70%. These measurements are called early repolarization duration (ERD) when they are located before the T-wave apex and late repolarization duration (LRD) when measured after the apex. They depend on both the speed of the repolarization process and the morphology of the T loop. Thirty-nine healthy individuals were exposed to sotalol in a crossover-design study. Sixteen ECGs were recorded per day during 3 days. The first day (day 0) was baseline; a single dose of sotalol (160 mg) was given during day 1, and a double dose was given during day 2 (320 mg). The plasma concentration of the drug was measured just before the ECG recordings. RESULTS The values of all investigated parameters revealed a dose-dependent effect of sotalol (in average between parameters, rho = 0.9, P < .001). Our investigations described profound and statistically significant changes in the morphology of the vectorial T loop for day 1 (peak effect of sotalol: DeltaERD(50%) = 23 +/- 6 msec, P < .05; DeltaLRD(50%) = 8 +/- 3 msec, P = .05) and day 2 (peak effect of sotalol: DeltaERD(50%) = 51 +/- 14 msec, P < .05; DeltaLRD(50%) = 20 +/- 12 msec, P = .05). When investigating the timing of peak drug concentration and peak effect of the drug on the various repolarization parameters, we found asynchrony between ERDs/LRDs (> or = 3.5 hours after dosing) and QTc/QTc apex profiles (< 3.5 hours after dosing), suggesting that the time of maximum prolongation on the repolarization process was not synchronized with the time of maximum drug-induced heterogeneity of repolarization. CONCLUSION This study describes the sotalol-induced changes of the T-loop morphology in healthy individuals based on novel vectocardiographic parameters. These observations might help in improving the next generation of ECG markers for the evaluation of drug cardiotoxicity.

[1]  Johannes J. Struijk,et al.  Classification of the long-QT syndrome based on discriminant analysis of T-wave morphology , 2006, Computers in Cardiology, 2005.

[2]  Wojciech Zareba,et al.  Spectrum of ST-T–Wave Patterns and Repolarization Parameters in Congenital Long-QT Syndrome: ECG Findings Identify Genotypes , 2000, Circulation.

[3]  L. Hondeghem.  TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability). , 2005, Novartis Foundation symposium.

[4]  Y Chen,et al.  Mechanism of the cardiotoxic actions of terfenadine. , 1993, JAMA.

[5]  Richard B. Devereux,et al.  Principal Component Analysis of the T Wave and Prediction of Cardiovascular Mortality in American Indians: The Strong Heart Study , 2002, Circulation.

[6]  M. Malik,et al.  Morphological algebraic models of the TU-wave patterns/in idiopathic long QT syndrome. , 2001, International journal of cardiology.

[7]  Charles Antzelevitch,et al.  Assessing predictors of drug-induced torsade de pointes. , 2003, Trends in pharmacological sciences.

[8]  Wojciech Zareba,et al.  A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology. , 2008, Heart rhythm.

[9]  Peter J. Schwartz,et al.  Diagnostic Criteria for the Long QT Syndrome An Update , 1993, Circulation.

[10]  Martin Hinterseer,et al.  Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study. , 2007, European heart journal.

[11]  M. Rosen,et al.  Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion. , 2007, Heart rhythm.

[12]  H. Wellens,et al.  Chronic Amiodarone Evokes No Torsade de Pointes Arrhythmias Despite QT Lengthening in an Animal Model of Acquired Long-QT Syndrome , 2001, Circulation.

[13]  S. Yuan,et al.  In vivo validation of the T-peak to T-end interval: implications for genesis of the T wave. , 2007, Heart rhythm.

[14]  Michael Christiansen,et al.  T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. , 2004, Heart rhythm.

[15]  M. Lehmann,et al.  T wave "humps" as a potential electrocardiographic marker of the long QT syndrome. , 1994, Journal of the American College of Cardiology.

[16]  J. Couderc,et al.  Electrocardiographic Method for Identifying Drug-induced Repolarization Abnormalities Associated with a Reduction of the Rapidly Activating Delayed Rectifier Potassium Current , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[17]  A. Moss,et al.  ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. , 1995, Circulation.

[18]  M. Yılmaz,et al.  Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake. , 2007, International journal of cardiology.

[19]  P. Kowey,et al.  Phase 2 Early Afterdepolarization as a Trigger of Polymorphic Ventricular Tachycardia in Acquired Long-QT Syndrome: Direct Evidence From Intracellular Recordings in the Intact Left Ventricular Wall , 2001, Circulation.

[20]  A. Moss,et al.  Impaired T‐Amplitude Adaptation to Heart Rate Characterizes IKr Inhibition in the Congenital and Acquired Forms of the Long QT Syndrome , 2007, Journal of cardiovascular electrophysiology.

[21]  Borje Darpo,et al.  Electrocardiographic Identification of Drug‐Induced QT Prolongation: Assessment by Different Recording and Measurement Methods , 2004, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[22]  Michael J. Black,et al.  A Non-Parametric Bayesian Approach to Spike Sorting , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[23]  A. Katchman,et al.  The antiestrogen tamoxifen blocks the delayed rectifier potassium current, IKr, in rabbit ventricular myocytes. , 1998, The Journal of pharmacology and experimental therapeutics.

[24]  Wojciech Zareba,et al.  Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin. , 2008, Drug safety.

[25]  P. Schwartz,et al.  Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. , 1994, Journal of the American College of Cardiology.

[26]  K. Hayashi,et al.  T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion , 2002, Clinical cardiology.

[27]  W. Shimizu,et al.  Exercise Stress Test Amplifies Genotype-Phenotype Correlation in the LQT1 and LQT2 Forms of the Long-QT Syndrome , 2003, Circulation.

[28]  D. Wysowski,et al.  Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions , 2001, American Journal of Gastroenterology.

[29]  Rémi Dubois,et al.  T‐Wave Morphology Parameters Based on Principal Component Analysis Reproducibility and Dependence on T−Offset Position , 2007, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[30]  O. Aslan,et al.  Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure. , 2006, International heart journal.

[31]  A J Moss,et al.  Long QT syndrome. New electrocardiographic characteristics. , 1990, Circulation.

[32]  S le Cessie,et al.  Risk of cardiac events in family members of patients with long QT syndrome. , 1995, Journal of the American College of Cardiology.

[33]  C Antzelevitch,et al.  Chronic Amiodarone Reduces Transmural Dispersion of Repolarization in the Canine Heart , 1997, Journal of cardiovascular electrophysiology.

[34]  G. Moe,et al.  Nonuniform Recovery of Excitability in Ventricular Muscle , 1964, Circulation research.

[35]  W. Zareba,et al.  Fractionated repolarization induced by sotalol in healthy subjects , 2005, Computers in Cardiology, 2005.

[36]  Taku Asano,et al.  Transmural dispersion of repolarization and ventricular tachyarrhythmias. , 2004, Journal of electrocardiology.

[37]  Charles Antzelevitch,et al.  Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. , 2007, American journal of physiology. Heart and circulatory physiology.